Product Information
DEXMETHYLPHENIDATE ER 30 MG CP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.7632 per EA under NDC 00093555401. Its NADAC has been published 632 times since Jul 16, 2014.
FDA first approved this application on Nov 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093555401
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202731FDA Approved
11/19/2013
TE Code
AB
On Market Since
5/22/2014
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has been published 632 times since Jul 16, 2014, and over the history we have for it it has declined 67.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7632 per EA |
|---|---|
| All-time high | $5.5686 (Jun 10, 2015) |
| All-time low | $0.7499 (May 22, 2024) |
| 52-week high | $2.0211 |
| 52-week low | $1.4839 |
| Median price | $3.3452 |
| Average price | $3.1925 |
| Largest weekly change | +83.4% (Aug 18, 2021) |
| Weeks tracked | 632 |
| Tracking since | Jul 16, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 30 MG CP, manufactured by Teva Pharmaceuticals USA Inc., is $1.7632 per EA (NDC 00093555401), effective Aug 19, 2026.
How has the price of DEXMETHYLPHENIDATE ER 30 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has declined 67.3%. It has been tracked across 632 weekly CMS publications since Jul 16, 2014.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 30 MG CP?
Since Jul 16, 2014, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has ranged from a low of $0.7499 (May 22, 2024) to a high of $5.5686 (Jun 10, 2015), with a median of $3.3452 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 30 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE ER 30 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXMETHYLPHENIDATE ER 30 MG CP?
DEXMETHYLPHENIDATE ER 30 MG CP (NDC 00093555401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.